Arsenic trioxide is an old drug in modern medicine that has demonstrated excellent clinical activity against acute promyelocytic leukemia (APML) harboring t(15;17) PML-RARA translocation [5,6]. Here, RARA is linked to acute promyelocytic leukemia.